About: We read with interest the narrative review by Arca et al. [1] on the use of headache medicines, specifically non‐steroidal anti‐inflammatory drugs (NSAIDs) and corticosteroids, amid novel coronavirus disease 2019 (COVID‐19) pandemic. Arca et al. [1] have comprehensively summarized current understanding of the risks and benefits of NSAIDs and corticosteroids to facilitate decision‐making by the clinicians. Nevertheless, we feel that headache medicines including the tricyclic antidepressant amitriptyline and the anticonvulsant valproate that possess the potential for weight gain are also worthy of discussion.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: We read with interest the narrative review by Arca et al. [1] on the use of headache medicines, specifically non‐steroidal anti‐inflammatory drugs (NSAIDs) and corticosteroids, amid novel coronavirus disease 2019 (COVID‐19) pandemic. Arca et al. [1] have comprehensively summarized current understanding of the risks and benefits of NSAIDs and corticosteroids to facilitate decision‐making by the clinicians. Nevertheless, we feel that headache medicines including the tricyclic antidepressant amitriptyline and the anticonvulsant valproate that possess the potential for weight gain are also worthy of discussion. Goto Sponge NotDistinct Permalink

An Entity of Type : fabio:Abstract, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	abstract
value	We read with interest the narrative review by Arca et al. [1] on the use of headache medicines, specifically non‐steroidal anti‐inflammatory drugs (NSAIDs) and corticosteroids, amid novel coronavirus disease 2019 (COVID‐19) pandemic. Arca et al. [1] have comprehensively summarized current understanding of the risks and benefits of NSAIDs and corticosteroids to facilitate decision‐making by the clinicians. Nevertheless, we feel that headache medicines including the tricyclic antidepressant amitriptyline and the anticonvulsant valproate that possess the potential for weight gain are also worthy of discussion.
part of	The use of pharmacological preventive therapy for migraine with weight gain potential amid COVID‐19 pandemic
is abstract of	The use of pharmacological preventive therapy for migraine with weight gain potential amid COVID‐19 pandemic

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software